Diseases, Conditions, Syndromes

Testing tuberculosis vaccine combinations for COVID-19

Researchers at the University of Sydney and Centenary Institute are repurposing an existing tuberculosis vaccine to see if it can be used in a new way against COVID-19 to develop a novel vaccine.

Diseases, Conditions, Syndromes

Promising pre-clinical results for COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan's (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards ...

Diseases, Conditions, Syndromes

Breakthrough in Zika virus vaccine

Researchers from the University of Adelaide have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of the disease.

Diseases, Conditions, Syndromes

UN: 'Substantial risks' remain in Congo's Ebola outbreak

The World Health Organization says "substantial risks" remain in the ongoing Ebola outbreak in northeastern Congo, noting that while control measures appear to be working, health officials are still unable to track exactly ...

Diseases, Conditions, Syndromes

Novel schistosomiasis vaccine: New phase of clinical studies

The Oswaldo Cruz Foundation (Fiocruz) at Rio de Janeiro, Brazil, will start the phase II clinical trials of a vaccine for schistosomiasis, called 'Sm14 Vaccine'. The initiative is one of the health research and development ...

Diseases, Conditions, Syndromes

FDA approves vaccine for cholera

In a milestone years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine's Center for Vaccine Development, was approved today by the U.S. Food ...

page 1 from 3